UK Venture Plans ‘Smart’ Randomized Trials To Speed Access To New Drugs
Sanofi Is First To Partner With Protas
Executive Summary
A newly launched UK venture is planning to use smart randomized clinical trial design in collaboration with industry, patient, academic and clinical partners to develop better treatments for a range of life-threatening diseases.